256940 · KOSDAQ · ₩256940 · 킵스파마
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−57.4% from the high
₩5,110Today: ₩5,170 – ₩5,490₩12,880
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals describe activity, not recommendations. Not financial advice.
Keeps Biopharma (킵스파마, KRX: 256940) is listed on KOSDAQ, in the Biotech & Pharma sector. The company operates in three segments: pharmaceuticals and biotech, lead battery recycling, and OLED display manufacturing equipment. Its shares closed at ₩5,490 on Oct 27, 2026, up 4.17% on the day, giving it a market value of ₩110B.
The company operates in three segments: pharmaceuticals and biotech, lead battery recycling, and OLED display manufacturing equipment. Its pharmaceutical units make and sell prescription drugs such as Gloderxi and Glostar tablets, develop oral peptide delivery platforms and anticancer candidates, and distribute drugs through its Korean subsidiaries. Its recycling unit produces recycled lead ingots from scrap, mainly waste batteries, for domestic and overseas battery makers, and its OLED unit develops and supplies equipment such as OLED mask tensioners to display panel makers in Korea, mainland China and other overseas markets.
Written by AI from the company's latest annual report.
Predicted impact: Low· Actual: −17.5% vs sector, volume 0.8× normal (5 trading days)
Subsidiary business shift into ESS; no size or revenue figures given.
Titles in Korean until English translations are added.
Also known as: Keeps Biopharma / 킵스파마 / 256940 / KRX:256940
Source: KRX statistical information